Causes of Delayed Presentation of MI Patients to a Tertiary Care Hospital

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

362 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-01

Study Completion Date

2024-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done to learn more about people who have had a heart attack, also called a myocardial infarction (MI). A heart attack happens when blood flow to the heart muscle is blocked, causing damage. The purpose of this study is to better understand the causes of delayed presentation and effects of the factors that caused delayed presentation.

We will collect information about patients' medical history, treatments, and recovery after their heart attack. This information may include blood tests, heart imaging, medications, and lifestyle factors. By studying these patients, we hope to find patterns that can help doctors predict complications, improve treatment, and reduce the chance of another heart attack.

The results of this study may help health care providers give better care and guidance to patients and families living with heart disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cardiovascular Risk Assessment Model in Patients With MI

NCT03957005

Myocardial Infarction, Acute

UNKNOWN

Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment

NCT03297164

Acute Myocardial Infarction Heart Failure

COMPLETED

Biomarkers in Acute Cardiac Care

NCT02355457

Acute Coronary Syndrome Myocardial Infarction Chest Pain

RECRUITING

Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction

NCT02641184

Coronary Artery Disease Percutaneous Coronary Intervention Acute Myocardial Infarction

UNKNOWN

The Prognosis of Acute Myocardial Infarction

NCT02737956

Acute Myocardial Infarction

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction DM HTN-Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational

no intervention was required for this cross sectional study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18 years and older with a confirmed diagnosis of myocardial infarction (STEMI or NSTEMI).
* Ability to provide informed consent (or consent from a legally authorized representative if patient is incapacitated).

Exclusion Criteria

* Severe comorbid illness (e.g., advanced cancer, end-stage renal or liver disease) that may limit survival or affect study outcomes.
* Inability to comply with follow-up requirements (e.g., cognitive impairment, lack of contact information, or unwillingness to participate)

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No